Skip to main content
Erschienen in: Current Bladder Dysfunction Reports 2/2014

01.06.2014 | Voiding Dysfunction Evaluation (C Gomez, Section Editor)

The Evaluation and Treatment of Adult Nocturnal Enuresis

verfasst von: Christopher James Hillary, Christopher Chapple

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Nocturnal enuresis is less common in adults than in childhood and is a significant cause of social and psychological debility and distress to patients, who may delay seeking treatment for fear of stigma. There is often an absence of significant underlying anatomical or functional pathology in patients with isolated nocturnal enuresis. A careful clinical assessment including a frequency-volume urine chart, post-voiding residual, and video-urodynamic assessment will identify the most appropriate treatment pathway by casting light on underlying pathophysiological abnormality. This will help direct the appropriate use of therapy whether it is desmopressin to reduce dieresis or an anticholinergic directed at detrusor overactivity. There is currently debate over the benefit of behavioral modification therapy, alarm systems and recently the role of posterior tibial nerve stimulation therapy in adult patients suffering from nocturnal enuresis. Adult onset nocturnal enuresis can be a sign of chronic retention and warrants urgent urological assessment and treatment.
Literatur
1.
Zurück zum Zitat Abrams P et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.PubMedCrossRef Abrams P et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.PubMedCrossRef
2.
Zurück zum Zitat Yeung CK et al. Characteristics of primary nocturnal enuresis in adults: an epidemiological study. BJU Int. 2004;93(3):341–5.PubMedCrossRef Yeung CK et al. Characteristics of primary nocturnal enuresis in adults: an epidemiological study. BJU Int. 2004;93(3):341–5.PubMedCrossRef
3.
Zurück zum Zitat Koff SA. Enuresis, in Campbell's Urology P.C. Walsh, Retik, A. B, Vaughan, Jr, et al, Editor., W. B. Saunders. p. 2065. Koff SA. Enuresis, in Campbell's Urology P.C. Walsh, Retik, A. B, Vaughan, Jr, et al, Editor., W. B. Saunders. p. 2065.
4.
Zurück zum Zitat Buckley BS, Lapitan MC. Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom. Int J Clin Pract. 2009;63(4):568–73.PubMedCrossRef Buckley BS, Lapitan MC. Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom. Int J Clin Pract. 2009;63(4):568–73.PubMedCrossRef
5.
Zurück zum Zitat Hellstrom AL et al. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. 1990;149(6):434–7.PubMedCrossRef Hellstrom AL et al. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. 1990;149(6):434–7.PubMedCrossRef
6.
7.
Zurück zum Zitat Yeung CK et al. Urodynamic findings in adults with primary nocturnal enuresis. J Urol. 2004;171(6 Pt 2):2595–8.PubMedCrossRef Yeung CK et al. Urodynamic findings in adults with primary nocturnal enuresis. J Urol. 2004;171(6 Pt 2):2595–8.PubMedCrossRef
8.
Zurück zum Zitat Harrison-Woolrych M et al. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry. 2011;199(2):140–4.PubMedCrossRef Harrison-Woolrych M et al. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry. 2011;199(2):140–4.PubMedCrossRef
9.
Zurück zum Zitat Light JK. Continence mechanisms following orthotopic bladder substitution. Scand J Urol Nephrol Suppl. 1992;142:95–7.PubMed Light JK. Continence mechanisms following orthotopic bladder substitution. Scand J Urol Nephrol Suppl. 1992;142:95–7.PubMed
10.
Zurück zum Zitat Zahariou A et al. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury. Eur Medicophys. 2007;43(3):333–8. Zahariou A et al. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury. Eur Medicophys. 2007;43(3):333–8.
11.
Zurück zum Zitat Ekinci O et al. Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample. Int J Hematol. 2013;98(4):430–6.PubMedCrossRef Ekinci O et al. Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample. Int J Hematol. 2013;98(4):430–6.PubMedCrossRef
12.
Zurück zum Zitat el-Bahnasawy MS et al. Persistent and occasional nocturnal enuresis in orthotopic urinary diversion: is there a urodynamic difference? BJU Int. 2005;96(9):1373–7.PubMedCrossRef el-Bahnasawy MS et al. Persistent and occasional nocturnal enuresis in orthotopic urinary diversion: is there a urodynamic difference? BJU Int. 2005;96(9):1373–7.PubMedCrossRef
13.
Zurück zum Zitat Goonewardena SA, Sivapriyan S. High pressure chronic retention: a life-threatening clinical entity. Ceylon Med J. 2005;50(2):71–3.PubMed Goonewardena SA, Sivapriyan S. High pressure chronic retention: a life-threatening clinical entity. Ceylon Med J. 2005;50(2):71–3.PubMed
14.
Zurück zum Zitat Ahmed AF et al. Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean J Urol. 2013;54(11):783–90.PubMedCentralPubMedCrossRef Ahmed AF et al. Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean J Urol. 2013;54(11):783–90.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Caldwell PH, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013;7, CD003637.PubMed Caldwell PH, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013;7, CD003637.PubMed
16.
17.
Zurück zum Zitat Lin AD et al. Nocturnal enuresis in older adults. J Chin Med Assoc. 2004;67(3):136–40.PubMed Lin AD et al. Nocturnal enuresis in older adults. J Chin Med Assoc. 2004;67(3):136–40.PubMed
18.
Zurück zum Zitat Rittig S et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256(4 Pt 2):F664–71.PubMed Rittig S et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256(4 Pt 2):F664–71.PubMed
19.
Zurück zum Zitat Stenberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics. 1994;94(6 Pt 1):841–6.PubMed Stenberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics. 1994;94(6 Pt 1):841–6.PubMed
20.
Zurück zum Zitat Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol. 1999;161(1):90–2.PubMed Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol. 1999;161(1):90–2.PubMed
21.
Zurück zum Zitat Yucel S et al. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood. Urology. 2004;64(5):1020–5. discussion 1025.PubMedCrossRef Yucel S et al. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood. Urology. 2004;64(5):1020–5. discussion 1025.PubMedCrossRef
22.
Zurück zum Zitat Burgu B et al. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults. Urology. 2009;74(4):915–9.PubMedCrossRef Burgu B et al. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults. Urology. 2009;74(4):915–9.PubMedCrossRef
23.•
Zurück zum Zitat Hajdinjak T, Leskovar J. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Sci World J. 2013. doi:10.1155/2013/878564. This study demonstrates that the effectiveness of desmopressin on nocturia is not dependant on the nocturnal bladder capacity index. Hajdinjak T, Leskovar J. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Sci World J. 2013. doi:10.​1155/​2013/​878564. This study demonstrates that the effectiveness of desmopressin on nocturia is not dependant on the nocturnal bladder capacity index.
24.
Zurück zum Zitat Weiss JP et al. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31(4):441–7.PubMedCrossRef Weiss JP et al. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31(4):441–7.PubMedCrossRef
25.
Zurück zum Zitat Lose G et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol. 2004;172(3):1021–5.PubMed Lose G et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol. 2004;172(3):1021–5.PubMed
26.•
Zurück zum Zitat Goldberg H, et al. Low-Dose Oral Desmopressin for Treatment of Nocturia and Nocturnal Enuresis in Patients after Radical Cystectomy and Orthotopic Urinary Diversion. BJU Int. 2013. doi: 10.1111/bju.12598. A significant proportion of patients with neobladders respond to night-time dose of desmopressin. Goldberg H, et al. Low-Dose Oral Desmopressin for Treatment of Nocturia and Nocturnal Enuresis in Patients after Radical Cystectomy and Orthotopic Urinary Diversion. BJU Int. 2013. doi: 10.​1111/​bju.​12598. A significant proportion of patients with neobladders respond to night-time dose of desmopressin.
27.
Zurück zum Zitat El-Bahnasawy MS et al. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol. 2008;42(4):344–51.PubMedCrossRef El-Bahnasawy MS et al. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol. 2008;42(4):344–51.PubMedCrossRef
28.
Zurück zum Zitat Jerlstrom T, Andersson G, Carringer M. Functional outcome of orthotopic bladder substitution: a comparison between the S-shaped and U-shaped neobladder. Scand J Urol Nephrol. 2010;44(4):197–203.PubMedCrossRef Jerlstrom T, Andersson G, Carringer M. Functional outcome of orthotopic bladder substitution: a comparison between the S-shaped and U-shaped neobladder. Scand J Urol Nephrol. 2010;44(4):197–203.PubMedCrossRef
29.
Zurück zum Zitat Hunsballe JM et al. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol. 1997;158(3 Pt 1):830–6.PubMedCrossRef Hunsballe JM et al. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol. 1997;158(3 Pt 1):830–6.PubMedCrossRef
30.••
Zurück zum Zitat Negro CL, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–4. An overview of the management of chronic urinary retention in men. PubMedCrossRef Negro CL, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–4. An overview of the management of chronic urinary retention in men. PubMedCrossRef
31.
Zurück zum Zitat Homma Y et al. Clinical guideline for male lower urinary tract symptoms. Int J Urol. 2009;16(10):775–90.PubMedCrossRef Homma Y et al. Clinical guideline for male lower urinary tract symptoms. Int J Urol. 2009;16(10):775–90.PubMedCrossRef
32.
Zurück zum Zitat Abeygunasekera AM et al. Significance of recent onset nocturnal enuresis in adult men: a prospective study. Ceylon Med J. 2004;49(3):79–81.PubMed Abeygunasekera AM et al. Significance of recent onset nocturnal enuresis in adult men: a prospective study. Ceylon Med J. 2004;49(3):79–81.PubMed
33.
Zurück zum Zitat Congregado Ruiz B et al. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 2004;45(1):65–9.PubMed Congregado Ruiz B et al. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 2004;45(1):65–9.PubMed
34.
Zurück zum Zitat de Oliveira LF et al. Transcutaneous parasacral electrical neural stimulation in children with primary monosymptomatic enuresis: a prospective randomized clinical trial. J Urol. 2013;190(4):1359–63.PubMed de Oliveira LF et al. Transcutaneous parasacral electrical neural stimulation in children with primary monosymptomatic enuresis: a prospective randomized clinical trial. J Urol. 2013;190(4):1359–63.PubMed
35.•
Zurück zum Zitat Raheem AA et al. Role of posterior tibial nerve stimulation in the treatment of refractory monosymptomatic nocturnal enuresis: a pilot study. J Urol. 2013;189(1514). A novel treatment for nocturnal enuresis in adults. Raheem AA et al. Role of posterior tibial nerve stimulation in the treatment of refractory monosymptomatic nocturnal enuresis: a pilot study. J Urol. 2013;189(1514). A novel treatment for nocturnal enuresis in adults.
36.
Zurück zum Zitat Fitzgerald MP et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1545–50.PubMedCentralPubMedCrossRef Fitzgerald MP et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1545–50.PubMedCentralPubMedCrossRef
Metadaten
Titel
The Evaluation and Treatment of Adult Nocturnal Enuresis
verfasst von
Christopher James Hillary
Christopher Chapple
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 2/2014
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-014-0237-8

Weitere Artikel der Ausgabe 2/2014

Current Bladder Dysfunction Reports 2/2014 Zur Ausgabe

Voiding Dysfunction Evaluation (C Gomez, Section Editor)

Transition of Care and Treatment of the Adult Spina Bifida Patient

Voiding Dysfunction Evaluation (C Gomez, Section Editor)

Evaluation and Management of Neurogenic Stress Urinary Incontinence

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Future Pharmacotherapies for Male Lower Urinary Tract Symptoms

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.